Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Bupivacaine · Bupivacaine Hydrochloride, Exparel

Small molecule · Inhibitor of voltage-gated sodium channel · developed by Hospira

Approved FDA, Jul 1983
15 Registered trials

What is Bupivacaine?

Bupivacaine is an amide-type long-acting local anesthetic that reversibly binds sodium ion channels in neuronal membranes, inhibiting depolarization and nerve impulse conduction. It is used to produce local or regional anesthesia and postsurgical analgesia, and is studied in postoperative and acute pain.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Bupivacaine Hydrochloride, Exparel, Marcaine, Sensorcaine, LIQ865B, LIQ865A, BR-003, LIQ865, SKY0402, Bupivacain, Marcaine Spinal
Drug type
Small molecule
Targets
voltage-gated sodium channel
Mechanism
Inhibitor of voltage-gated sodium channel
Pathways
nerve impulse conduction, sodium ion permeability
Therapy area
Cardiovascular, Neurology
Developer
Hospira
In trials of
HRTX, LQDA, PCRX
FDA status
Approved as Bupivacaine Hydrochloride, Exparel, Marcaine (July 13, 1983), NDA022046 · FDA label
UNII
Y8335394RO

✅ FDA-approved uses

From the indications section of the FDA label (version of Jun 24, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05109312 Phase 4 Analgesia Active not recruiting HRTX
NCT03827291 Phase 4 Laparotomy Completed PCRX
NCT03705065 Phase 4 Postoperative Pain Completed HRTX
NCT04102267 Phase 4 Analgesia Completed HRTX
NCT02058303 Phase 4 Hand Injuries Terminated PCRX
NCT07212114 Phase 3 Total Ankle Arthroplasty Recruiting PCRX
NCT06350981 Phase 2/3 Back Pain Enrolling by invitation PCRX
NCT06077422 Phase 2/3 Pain, Postoperative Enrolling by invitation PCRX
NCT05157841 Phase 3 Bunionectomy Completed PCRX
NCT05171179 Phase 3 Mammaplasty Completed PCRX
NCT03974932 Phase 3 Analgesia Completed HRTX
NCT04911062 Phase 2 Post-Operative Pain Completed HRTX
NCT03011333 Phase 2 Postoperative Pain Completed HRTX
NCT04293809 Phase 1 Breast Augmentation Completed PCRX
NCT02982889 Phase 1 Acute Pain Completed LQDA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Back PainHeart DiseasesNarcotic UseOpioid UsePain, PostoperativePerioperative ComplicationPhysical StressPost Operative PainPostsurgical AnalgesiaSurgery-ComplicationsTotal Ankle ArthroplastyAcute PainAnalgesiaBreast Augmentation

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.